BusinessAgile Therapeutics Announces Positive Top-line Phase 3 ResultsBy Nasdaq OMXJan 3, 2017, 9:11 PM UTC
BusinessAgile Therapeutics Appoints Ajit S. Shetty, Ph.D., to Its Board of DirectorsBy Nasdaq OMXFeb 24, 2016, 9:15 PM UTC